Market Research Logo

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Thailand

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Thailand

Summary

GlobalData, the industry analysis specialist, has released its latest report, “CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Thailand”. The report is an essential source of information on and analysis of the healthcare, regulatory and reimbursement landscape in Thailand. It identifies the key trends in the country’s healthcare market and provides insights into its demographic, regulatory, and reimbursement landscape and healthcare infrastructure. Most importantly, the report provides valuable insights into the trends and segmentation of its pharmaceutical and medical device markets. It uses data and information sourced from proprietary databases, secondary research, and in-house analysis by GlobalData’s team of industry experts.

In 2015, the population of Thailand 68.84 million, and it is estimated to reach 69.31 million by 2020. The value of the pharmaceutical market was estimated at $5.91 billion in 2015, and is expected to reach $9.47 billion in 2020, increasing at a projected CAGR of 10%.

The positive trends in the healthcare market of Thailand can be attributed primarily to -

  • Increasing medical tourism
  • Increasing health awareness
  • Greater access to life-saving facilities
Scope

The report provides information on the healthcare, regulatory, and reimbursement landscape in Thailand, and includes -
  • An overview of the pharmaceutical and medical device markets, including size, segmentation, and key drivers and barriers
  • Profiles and SWOT analyses of the major players in the pharmaceutical and medical device markets. The key players covered for the pharmaceutical market are GlaxoSmithKline (GSK), Sanofi, Roche, AstraZeneca and Novartis.
  • An insightful review of the reimbursement and regulatory landscape, with details of the reimbursement process, regulatory agencies, and market authorization processes for new drug and medical devices
  • Detailed analysis of the political and economic environment, including economic indicators, demographics, healthcare infrastructure, and healthcare expenditures
  • An overview of the opportunities and challenges for growth in the healthcare market
Reasons to buy

This report will enhance your decision-making capability by allowing you to -
  • Develop business strategies by understanding the trends shaping and driving Thailand’s healthcare market
  • Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments and companies likely to impact Thailand’s healthcare market in the future
  • Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing competitors’ performance
  • Organize your sales and marketing efforts by identifying the market categories and segments that present the most opportunities for consolidation, investment and strategic partnership


1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 GlobalData Report Guidance
3 Overview of Pharmaceutical and Medical Device Markets
3.1 Pharmaceutical Market
3.1.1 Market Overview
3.1.2 Pharmaceutical Import and Export
3.1.3 Supply Channels
3.1.4 Market Segments
3.1.5 Major Therapeutic Areas
3.1.6 Major Companies
3.2 Medical Device Market
3.2.1 Market Overview
3.3 Market Drivers and Barriers
3.3.1 Drivers
3.3.2 Barriers
4 Market Access
4.1 Reimbursement and Payer Landscape
4.1.1 Overview of Healthcare system
4.1.2 Reimbursement Process
4.1.3 Overview of Insurance Providers
4.1.4 Patient Share in Healthcare Spending
4.1.5 Price Trends in the Healthcare Sector
4.1.6 Pricing Policies
4.2 Regulatory Landscape
4.2.1 Overview of Regulatory Agencies
4.2.2 Market Authorization Procedure for Pharmaceutical Products
4.2.3 New Medical Device Approval Process
4.2.4 Licensing Process for Pharmaceutical and Medical Device Manufacturing
4.2.5 Licensing Process for Pharmaceutical Exports and Imports
4.2.6 Intellectual Property Rights
4.2.7 Clinical Trial Regulations
4.2.8 Pharmaceutical Advertising Regulations
4.2.9 Pharmacy Regulations
4.2.10 Labelling and Packaging Regulations
5 Country Analysis
5.1 Political Environment
5.1.1 Political Structure
5.1.2 Analysis of the Current Political Environment
5.1.3 Healthcare Policy Initiatives
5.2 Economic Landscape
5.3 Economic Indicators
5.3.1 Gross Domestic Product
5.3.2 Gross National Income
5.3.3 Inflation
5.3.4 Currency Exchange Rate
5.3.5 Foreign Direct Investment
5.3.6 Foreign Exchange Reserves
5.3.7 Trade Balance
5.3.8 Government Structural Balance
5.3.9 Government Net Debt
5.3.10 Major Industries
5.4 Demographics
5.4.1 Population
5.4.2 Education and Literacy
5.4.3 Employment
5.4.4 Disease Burden
5.5 Healthcare Infrastructure
5.5.1 Healthcare Facilities
5.5.2 Healthcare Parameters
5.5.3 Environmental Health
5.5.4 Healthcare Personnel
5.6 Healthcare Expenditure
5.6.1 Overview of Healthcare Expenditure
5.6.2 Major Components of Healthcare Expenditure
5.6.3 Healthcare Expenditure Distribution
5.6.4 Spending in Pharmaceutical R&D
5.7 Trade Associations
5.7.1 Thai Pharmaceutical Manufacturers Association
5.7.2 Thai Medical Technology Industry Association
5.7.3 Thai Self-Medication Industry Association
5.7.4 The Medical Association of Thailand
5.8 Trade Fairs
6 Opportunities and Challenges
6.1 Opportunities
6.2 Challenges
7 Appendix
7.1 Abbreviations
7.2 Bibliography
7.3 Research Methodology
7.3.1 Coverage
7.3.2 Secondary Research
7.3.3 Forecasts
7.3.4 Expert Panel
7.4 Disclaimer
1.1 List of Tables
Table 1: Pharmaceutical Market, Israel, Revenue ($bn), 2008-2015
Table 2: Pharmaceutical Market, Israel, Revenue ($bn), 2016-2020
Table 3: Pharmaceutical Market, Israel, Exports and Imports ($bn), 2008-2015
Table 4: Pharmaceutical Market, Israel, Over-the-Counter Market, Revenue ($m), 2008-2015
Table 5: Pharmaceutical Market, Teva, Global Revenue of Major Products, 2015
Table 6: Pharmaceutical Market, Teva, Late-Stage Pipeline, 2016
Table 7: Pharmaceutical Market, Taro, Global, Major Products, 2016
Table 8: Pharmaceutical Market, Dexcel, Israel, Products, 2016
Table 9: Pharmaceutical Market, Rekah, Israel, Products, 2016
Table 10: Medical Device Market, Israel, Revenue ($bn), 2008-2015
Table 11: Medical Device Market, Israel, Revenue ($bn), 2016-2020
Table 12: Medical Device Market, Israel, Revenue by Segment ($m), 2015
Table 13: Medical Device Market, Israel, Nephrology and Urology Devices ($m), 2008-2015
Table 14: Nephrology and Urology Devices, Israel, Revenue ($m) and Market Share (%) of Leading Companies, 2012
Table 15: Medical Device Market, Israel, In Vitro Diagnostics ($m), 2008-2015
Table 16: In Vitro Diagnostics, Israel, Revenue ($m) and Market Share (%) of Leading Companies, 2012
Table 17: Medical Device Market, Israel, Cardiovascular Devices ($m), 2008-2015
Table 18: Cardiovascular Devices, Israel, Revenue ($m) and Market Share (%) of Leading Companies, 2015
Table 19: Medical Device Market, Israel, Ophthalmic Devices ($m), 2008-2015
Table 20: Ophthalmic Devices, Israel, Revenue ($m) and Market Share (%) of Leading Companies, 2012
Table 21: Medical Device Market, Israel, Drug Delivery Devices Market ($m), 2008-2015
Table 22: Drug Delivery Devices Market, Israel, Revenue ($m) and Market Share (%) of Leading Companies, 2012
Table 23: Medical Device Market, Israel, Revenue ($m) and Market Share (%) of Leading Companies, 2015
Table 24: Medical Device Market, Medtronic, Major Products, 2015
Table 25: Siemens, Global, Major Products, 2015
Table 26: Medical Device Market, Boston Scientific, Major Products by Revenue ($bn), 2016
Table 27: Roche, Global, Major Products, 2016
Table 28: Medical Device Market, Roche, Global, Late-Stage Pipeline, 2016
Table 29: Healthcare System, Israel, Contribution Rates for Insurance Based on Employment, 2014
Table 30: Healthcare Spending, Israel, Co-payments Cap for Chronically ill Patients, HMO, 2016
Table 31: Healthcare Spending, Israel, Out-of-Pocket Expenditure (%), 2008-2014
Table 32: Market Access, Israel, Change in Prices of Medicines (%), 2008-2015
Table 33: Economic Indicators, Israel, Gross Domestic Product per Capita ($), 2008-2015
Table 34: Economic Indicators, Israel, Gross Domestic Product per Capita ($), 2016-2020
Table 35: Economic Indicators, Israel, Gross Domestic Product Annual Growth (%), 2008-2015
Table 36: Economic Indicators, Israel, Gross Domestic Product Annual Growth (%), 2016-2020
Table 37: Economic Indicators, Israel, Gross National Income per Capita ($), 2008-2015
Table 38: Economic Indicators, Israel, Average Consumer Price Index, 2008-2015
Table 39: Economic Indicators, Israel, Average Consumer Price Annual Change (%), 2008-2015
Table 40: Economic Indicators, Israel, Currency Exchange Rate (ILS/$), 2008-2015
Table 41: Economic Indicators, Israel, Foreign Direct Investment ($bn), 2008-2015
Table 42: Economic Indicators, Israel, Foreign Exchange Reserves ($bn), 2008-2015
Table 43: Economic Indicators, Israel, Imports of Goods and Services ($bn), 2008-2015
Table 44: Economic Indicators, Israel, Exports of Goods and Services ($bn), 2008-2015
Table 45: Economic Indicators, Israel, Government Structural Balance ($bn), 2008-2015
Table 46: Economic Indicators, Israel, General Government Net Debt as Percentage of GDP (%), 2008-2015
Table 47: Economic Indicators, Israel, Major Industries by Revenue (%), 2014
Table 48: Demographics, Israel, Population (million), 2008-2015
Table 49: Demographics, Israel, Population (million), 2016-2020
Table 50: Demographics, Israel, Population, Urban and Rural Population Share (%), 2008-2015
Table 51: Demographics, Israel, Population, Urban and Rural Population Share (%), 2014-2020
Table 52: Demographics, Israel, Population Distribution by Age Group (%), 2008-2015
Table 53: Demographics, Israel, Population Distribution by Age Group (%), 2016-2020
Table 54: Demographics, Israel, Births (per 1,000 population), 2008-2014
Table 55: Demographics, Israel, Mortality (per 1,000 population), 2008-2014
Table 56: Demographics, Israel, Major Causes of Mortality, 2013
Table 57: Demographics, Israel, Infant Mortality (per 1,000 live births), 2008-2015
Table 58: Demographics, Israel, Immunization Rate (%), 2008-2014
Table 59: Demographics, Israel, Major Causes of Male Mortality (per 100,000 population), 2013
Table 60: Demographics, Israel, Major Causes of Female Mortality (per 100,000 population), 2013
Table 61: Demographics, Israel, Gender Ratio (M/F), 2008-2015
Table 62: Demographics, Israel, Life Expectancy at Birth (years), 2008-2015
Table 63: Demographics, Israel, Life Expectancy at Birth (years), 2016-2020
Table 64: Demographics, Israel, Enrollment by Level of Education (%), 2009-2014
Table 65: Demographics, Israel, Unemployment Rate (%), 2008-2015
Table 66: Demographics, Israel, Distribution of Male Employment by Occupation (%), 2014
Table 67: Demographics, Israel, Distribution of Female Employment by Occupation (%), 2014
Table 68: Demographics, Israel, Number of Reported Cases per Disease (per 1,000 population), 2009
Table 69: Demographics, Israel, Major Diseases, Disability-Adjusted Life Years (‘000), 2012
Table 70: Healthcare Infrastructure, Israel, Number of Hospital Establishments, 2008-2014
Table 71: Healthcare Infrastructure, Israel, Public and Private Hospitals, 2008-2014
Table 72: Healthcare Infrastructure, Israel, Type of Hospital Care, 2008-2014
Table 73: Healthcare Infrastructure, Israel, Diagnostic Equipment (per million population), 2008-2015
Table 74: Healthcare Infrastructure, Israel, Hospital Beds (per 1,000 population), 2008-2015
Table 75: Healthcare Infrastructure, Israel, Doctors (per 1,000 population), 2008-2014
Table 76: Healthcare Infrastructure, Israel, PM10 (µg/m3), 2008-2014
Table 77: Healthcare Infrastructure, Israel, Carbon Dioxide Emissions (million metric tons), 2008-2014
Table 78: Healthcare Infrastructure, Israel, Nurses (per 1,000 population), 2008-2014
Table 79: Healthcare Infrastructure, Israel, Pharmacists (per 1,000 population), 2008-2014
Table 80: Healthcare Infrastructure, Israel, Dentists (per 1,000 population), 2008-2014
Table 81: Healthcare Expenditure, Israel, Healthcare Expenditure as a Percentage of GDP (%), 2008-2015
Table 82: Healthcare Expenditure, Israel, Public-Private Share (%), 2008-2013
Table 83: Healthcare Expenditure, Israel, Primary Healthcare Expenditure by Sector (%), 2012
Table 84: Healthcare Expenditure, Israel, Financing Agents (%), 2010
Table 85: Healthcare Expenditure, Israel, GDP Expenditure on R&D in Sciences ($bn), 2008-2014
Table 86: Healthcare Expenditure, Israel, Major Healthcare Trade Fairs, 2014
1.2 List of Figures
Figure 1: Pharmaceutical Market, Thailand, Revenue ($bn), 2008-2015
Figure 2: Pharmaceutical Market, Thailand, Revenue ($bn), 2016-2020
Figure 3: Pharmaceutical Imports and Exports, Thailand, Revenue ($bn), 2008-2015
Figure 4: Pharmaceutical Industry, Thailand, Structure, 2016
Figure 5: Pharmaceutical Market, Thailand, Pharmaceutical Product Sales by Segment (%), 2015
Figure 6: Major Therapeutic Areas, Thailand, Prevalence (%), 2010
Figure 7: Medical Device Market, Thailand, Revenue ($bn), 2008-2015
Figure 8: Medical Device Market, Thailand, Revenue ($bn), 2016-2020
Figure 9: Drivers and Barriers, Healthcare Market, Thailand, 2016
Figure 10: Reimbursement Fund Flow, Thailand, 2016
Figure 11: Health Insurance Development, Thailand, 2016
Figure 12: Addition to National List of Essential Drugs, Thailand, 2016
Figure 13: Drug Procurement Process, Thailand, 2016
Figure 14: Health Benefits Coverage, Thailand, 2011
Figure 15: Market Access, Thailand, Patient Share of Total Health Expenditure (%), 2008-2015
Figure 16: Market Access, Thailand, Producer Price Change (%), 2008-2015
Figure 17: Food and Drug Administration, Thailand, Structure, 2016
Figure 18: Marketing Authorization Procedure, New Drugs, Thailand, 2016
Figure 19: Marketing Authorization Procedure, Generics, Thailand, 2016
Figure 20: Marketing Authorization Procedure, New Generic Drugs, Thailand, 2016
Figure 21: Import Licensing Process for General Medical Device, Thailand, 2016
Figure 22: Patent Approval Process, Thailand, 2016
Figure 23: Trademark Approval Process, Thailand, 2016
Figure 24: Clinical Trial Regulation Process, Thailand, 2016
Figure 25: Economic Indicators, Thailand, Gross Domestic Product per Capita ($), 2008-2015
Figure 26: Economic Indicators, Thailand, Gross Domestic Product per Capita ($), 2016-2020
Figure 27: Economic Indicators, Thailand, Gross Domestic Product Annual Growth (%), 2008-2015
Figure 28: Economic Indicators, Thailand, Gross Domestic Product Annual Growth (%), 2016-2020
Figure 29: Economic Indicators, Thailand, Gross National Income per Capita ($), 2008-2015
Figure 30: Economic Indicators, Thailand, Consumer Price Index, 2008-2015
Figure 31: Economic Indicators, Thailand, Consumer Price Index, 2016-2020
Figure 32: Economic Indicators, Thailand, Average Consumer Price Annual Change (%), 2008-2015
Figure 33: Economic Indicators, Thailand, Average Consumer Price Annual Change (%), 2016-2020
Figure 34: Economic Indicators, Thailand, Currency Exchange Rate (THB/$), 2008-2015
Figure 35: Economic Indicators, Thailand, Foreign Direct Investment ($bn), 2008-2014
Figure 36: Economic Indicators, Thailand, Foreign Exchange Reserves ($bn), 2008-2014
Figure 37: Economic Indicators, Thailand, Imports of Goods and Services ($bn), 2008-2014
Figure 38: Economic Indicators, Thailand, Exports of Goods and Services ($bn), 2008-2014
Figure 39: Economic Indicators, Thailand, Government Structural Balance ($bn), 2008-2015
Figure 40: Economic Indicators, Thailand, General Government Net Debt (% of GDP), 2008-2015
Figure 41: Economic Indicators, Thailand, General Government Net Debt (% of GDP), 2016-2020
Figure 42: Major Industries, Thailand, Share of GDP at Current Market Prices (%), 2014
Figure 43: Demographics, Thailand, Population (million), 2008-2015
Figure 44: Demographics, Thailand, Population (million), 2016-2020
Figure 45: Demographics, Thailand, Population, Urban and Rural Population Share (%), 2008-2015
Figure 46: Demographics, Thailand, Population, Urban and Rural Population Share (%), 2016-2020
Figure 47: Demographics, Thailand, Population Distribution (%), 2008-2015
Figure 48: Demographics, Thailand, Population Distribution (%), 2016-2020
Figure 49: Demographics, Thailand, Births (per 1,000 population), 2008-2015
Figure 50: Demographics, Thailand, Mortality (per 1,000 population), 2008-2015
Figure 51: Demographics, Major Causes of Mortality, Thailand, Share of Total Mortality (%), 2014
Figure 52: Demographics, Thailand, Children Under Five Years of Age, Infant Mortality (per 1,000 live births), 2008-2015
Figure 53: Demographics, Thailand, Immunization Rate (%), 2008-2015
Figure 54: Demographics, Thailand, Major Causes of Male Mortality (Share %), 2010
Figure 55: Demographics, Thailand, Major Causes of Female Mortality (Share %), 2010
Figure 56: Demographics, Thailand, Gender Ratio (M/F), 2008-2015
Figure 57: Demographics, Thailand, Life Expectancy at Birth (years), 2008-2015
Figure 58: Demographics, Thailand, Life Expectancy at Birth (Years), 2016-2020
Figure 59: Demographics, Thailand, Gross Enrolment Ratio (%), 2008-2015
Figure 60: Demographics, Thailand, Unemployment Rate (%), 2008-2015
Figure 61: Demographics, Thailand, Major Diseases, DALYs, 2012
Figure 62: Healthcare Infrastructure, Thailand, Hospitals, 2008-2015
Figure 63: Healthcare Infrastructure, Thailand, Public and Private Hospitals, 2008-2015
Figure 64: Healthcare Infrastructure, Thailand, Hospitals by Standard of Care, Share (%), 2010
Figure 65: Healthcare Infrastructure, Thailand, Hospital Beds by Authority and Region, Share (%), 2010
Figure 66: Healthcare Infrastructure, Thailand, Hospital Beds (per 1,000 population), 2008-2015
Figure 67: Healthcare Infrastructure, Thailand, Doctors (per 1,000 population), 2008-2015
Figure 68: Healthcare Infrastructure, Thailand, PM2.5 emissions (µgm/m³), 2008-2015
Figure 69: Healthcare Infrastructure, Thailand, CO2 Emissions (Metric Tons Per Capita), 2008-2015
Figure 70: Healthcare Infrastructure, Thailand, Dentists (per 100,000 population), 2008-2015
Figure 71: Healthcare Infrastructure, Thailand, Nurses (per 100,000 population), 2008-2015
Figure 72: Healthcare Infrastructure, Thailand, Pharmacists (per 100,000 population), 2008-2015
Figure 73: Healthcare Expenditure (% of GDP), Thailand, 2008-2015
Figure 74: Healthcare Expenditure, Thailand, Major Components of Healthcare Expenditure (%), 2012
Figure 75: Healthcare Expenditure, Thailand, Public and Private Shares of GDP (%), 2008-2015
Figure 76: Healthcare Expenditure, Thailand, R&D Expenditure (% of GDP), 2008-2015
Figure 77: Healthcare Market, Thailand, Opportunities and Challenges, 2016

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report